| Observing the cell in its native state: Imaging subcellular dynamics in multicellular organisms TL Liu, S Upadhyayula, DE Milkie, V Singh, K Wang, IA Swinburne, ... Science 360 (6386), eaaq1392, 2018 | 569 | 2018 |
| AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion B Cunniff, AJ McKenzie, NH Heintz, AK Howe Molecular biology of the cell 27 (17), 2662-2674, 2016 | 222 | 2016 |
| Miro1-mediated mitochondrial positioning shapes intracellular energy gradients required for cell migration MH Schuler, A Lewandowska, GD Caprio, W Skillern, S Upadhyayula, ... Molecular biology of the cell 28 (16), 2159-2169, 2017 | 153 | 2017 |
| Oxidative processing of latent Fas in the endoplasmic reticulum controls the strength of apoptosis V Anathy, E Roberson, B Cunniff, JD Nolin, S Hoffman, P Spiess, ... Molecular and cellular biology 32 (17), 3464-3478, 2012 | 66 | 2012 |
| Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells K Newick, B Cunniff, K Preston, P Held, J Arbiser, H Pass, B Mossman, ... PloS one 7 (6), e39404, 2012 | 65 | 2012 |
| ROS production by mitochondria: function or dysfunction? FR Palma, BN Gantner, MJ Sakiyama, C Kayzuka, S Shukla, R Lacchini, ... Oncogene 43 (5), 295-303, 2024 | 55 | 2024 |
| Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells B Cunniff, K Benson, J Stumpff, K Newick, P Held, D Taatjes, J Joseph, ... Journal of cellular physiology 228 (4), 835-845, 2013 | 51 | 2013 |
| Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells B Cunniff, AN Wozniak, P Sweeney, K DeCosta, NH Heintz Redox Biology 3, 79-87, 2014 | 48 | 2014 |
| Peroxiredoxins and beyond; redox systems regulating lung physiology and disease EA Elko, B Cunniff, DJ Seward, SB Chia, R Aboushousha, ... Antioxidants & Redox Signaling 31 (14), 1070-1091, 2019 | 37 | 2019 |
| A direct and continuous assay for the determination of thioredoxin reductase activity in cell lysates B Cunniff, GW Snider, N Fredette, RJ Hondal, NH Heintz Analytical biochemistry 443 (1), 34-40, 2013 | 37 | 2013 |
| Lung organoids: advances in generation and 3D-visualization B Cunniff, JE Druso, JL van der Velden Histochemistry and Cell Biology 155 (2), 301-308, 2021 | 36 | 2021 |
| Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine B Cunniff, GW Snider, N Fredette, J Stumpff, RJ Hondal, NH Heintz Redox Biology 2, 475-484, 2014 | 31 | 2014 |
| Miro1-mediated mitochondrial positioning supports subcellular redox status H Alshaabi, N Shannon, R Gravelle, S Milczarek, T Messier, B Cunniff Redox Biology 38, 101818, 2021 | 30 | 2021 |
| Disabling mitochondrial peroxide metabolism via combinatorial targeting of peroxiredoxin 3 as an effective therapeutic approach for malignant mesothelioma B Cunniff, K Newick, KJ Nelson, AN Wozniak, S Beuschel, B Leavitt, ... PLoS One 10 (5), e0127310, 2015 | 27 | 2015 |
| Dynamic regulation of subcellular mitochondrial position for localized metabolite levels H Alshaabi, M Heininger, B Cunniff The journal of biochemistry 167 (2), 109-117, 2020 | 14 | 2020 |
| DRP1-mediated mitochondrial fission regulates lung epithelial response to allergen SR Bruno, A Kumar, ZF Mark, R Chandrasekaran, E Nakada, ... International journal of molecular sciences 22 (20), 11125, 2021 | 11 | 2021 |
| Unique cellular and biochemical features of human mitochondrial peroxiredoxin 3 establish the molecular basis for its specific reaction with thiostrepton KJ Nelson, T Messier, S Milczarek, A Saaman, S Beuschel, U Gandhi, ... Antioxidants 10 (2), 150, 2021 | 9 | 2021 |
| Direct assay of thioredoxin reductase activity RJ Hondal, NH Heintz, B Cunniff, N Fredette, GW Snider US Patent App. 14/460,759, 2015 | 6 | 2015 |
| Mitochondrial trafficking and redox/phosphorylation signaling supporting cell migration phenotypes N Shannon, R Gravelle, B Cunniff Frontiers in Molecular Biosciences 9, 925755, 2022 | 4 | 2022 |
| 1643TiP First-in-human dose-escalation and expansion study (MITOPE) to evaluate mitochondrial PRX3 inhibition by RSO-021 in patients with mesothelioma and other advanced solid … S Dulloo, DA Fennell, PW Szlosarek, F Thistlethwaite, S Lord, ... Annals of Oncology 33, S1292-S1293, 2022 | 1 | 2022 |
